In this article, we are going to take a look at where Akero Therapeutics Inc. (NASDAQ:AKRO) stands against the other stocks.
In this article, we are going to take a look at where Akero Therapeutics, Inc. (NASDAQ:AKRO) stands against other best performing healthcare stocks so far in 2025. Despite the ongoing craze ...
Bank of America Securities analyst Jason Zemansky maintained a Buy rating on Akero Therapeutics (AKRO – Research Report) on February 28 and set a price target of $63.00. The company’s shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results